Analgesics in New Zealand

Analgesics in New Zealand

Analgesics is set to see slow retail current value growth in New Zealand in 2024. During the period 2020-2021, the government’s response to the COVID-19 pandemic included movement restrictions and reduced levels of social interaction, which meant that incidences of seasonal cold and flu reduced year-over-year, which should have had a negative impact on sales of analgesics. Nevertheless, demand was instead driven by demand to relieve the symptoms of COVID-19. With reduced exposure to cold and flu...

Euromonitor International's Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.